MDA Space: Record Revenue, Decent Pipeline, And A Defense Pivot

Shares are up 42% since January, yet MDA Space still trades at multiples comparable to slower-growing peers L3Harris and Northrop Grumman. Gross margin contraction is due to a revenue mix shift, not operational inefficiency, while adjusted EBITDA held at ~20%. Management guides 18-20% adjusted EBITDA for 2026, signaling a well-understood floor for profitability.

Analysis

The market is effectively pricing a narrative that conflates short-term margin profile with permanent operating deterioration; because the margin move is predominantly a product/mix rotation rather than structural cost creep, the company can re-lever EBIT to revenue growth as higher-margin programs scale. That implies a path where multiple expansion is driven less by operational fixes and more by clearer forward-looking revenue cadence and program-level margin normalization over the next 6–18 months.

Competitive spillovers favor specialist subsystem suppliers and integrators that sit upstream of program mix shifts: vendors of RF front-ends, payload integration houses and mission software providers will see order book reallocation faster than legacy prime contractors whose valuation is anchored to slower organic growth. Conversely, large primes with broad defense exposure could face multiple compression if investors start differentiating growth profiles within the sector rather than valuing it as a single-duration cash generator.

Key risks that can reverse the thesis are timing slips in funded backlog conversion, single-contract concentration shock, and a near-term narrowing of defense budgets or procurement cadence — each can re-introduce margin volatility and force multiple re-rating within weeks. The asymmetric near-term payoff favors exposure that captures upside from clearer program execution over 3–12 months while capping dollar downside from headline-driven malaise; structuring trades via pair and options strategies preserves optionality and reduces macro beta.

Key Decisions for Investors

• Pair trade (6–12 months): Long MDA equity (size 2–3% NAV) funded by short LHX (equal dollar, size 1–1.5% NAV). Rationale: capture multiple expansion differential if program-level margins re-normalize; target +40–60% upside on the long leg vs ~15–25% downside if catch-up fails. Tight stop: 15% on the long leg or unwind if defense funding language materially changes.
• Options asymmetric (9–12 months): Buy MDA calendar/vertical call spread (long-dated calls financed by shorter-dated calls sold) to play re-rate while limiting premium. Risk/reward: capped maximum loss equal to net premium (~100% of premium) with potential 2–4x upside if multiple re-rates and revenue print surprises to the upside.
• Relative value short (3–6 months): Buy protection on NOC (buy 6–9 month puts or put spreads) sized 50–75% of MDA long exposure to hedge sector beta and capture near-term downside if large-prime earnings guidance disappoints. Expect hedge to pay off on any broad defense spending headlines; cost should be ~1–2% NAV.
• Liquidity/tactical: If MDA prints two consecutive quarters of margin stabilization plus backlog conversion beats, increase long to 4–6% NAV and reduce short LHX/NOC exposure by half to capture outright re-rating. Conversely, if backlog conversion misses or program cancellation risk materializes, exit longs and keep small protective shorts for 30–60 days.